TLDR
- LRCX hit an all-time high of $275.99, up 5.56% on the day
- The stock has returned 252% over the past year
- Multiple analysts have raised price targets, ranging from $310 to $340
- SVP Neil Fernandes sold $4.6M in stock on May 1 under a pre-planned 10b5-1 trading plan
- U.S. restrictions on tool shipments to China’s Hua Hong present a regulatory headwind
Lam Research (LRCX) hit an all-time high of $275.99 on May 5, 2026, gaining over 5.5% on the day. The move puts the stock’s one-year total return at 252%, a run that has pushed the company’s market cap to $343 billion.
Lam Research Corporation, LRCX
Revenue has grown roughly 27% over the last twelve months. The company’s Piotroski Score sits at a perfect 9, a measure of financial health tracked by InvestingPro.
The stock trades at a P/E ratio of 48.75. InvestingPro’s analysis flags LRCX as potentially overvalued relative to its Fair Value estimate.
Wall Street has been busy updating its outlook. Stifel raised its price target to $325 after LRCX’s fiscal Q3 results beat both its own and consensus estimates. The firm kept its Buy rating.
TD Cowen went further, lifting its target to $340. The firm pointed to market share gains in foundry and DRAM, plus expected growth in NAND wafer fabrication equipment spending.
Cantor Fitzgerald held its Overweight rating with a $320 target. It cited an improved outlook for wafer fabrication equipment through calendar year 2026, with projected sector growth of at least 27%.
UBS kept its Buy rating with a $310 target, noting LRCX is entering what it calls an AI-driven growth cycle.
Insider Sale Draws Attention
On May 1, Senior Vice President Neil Fernandes sold 18,170 shares at $255.14 each, totaling around $4.64 million. The sale was executed under a Rule 10b5-1 plan that Fernandes put in place on November 17, 2025.
After the transaction, Fernandes holds 66,129 shares directly. He also holds just over 1,015 shares indirectly through a 401(k).
Pre-planned sales like this are common among executives and don’t necessarily reflect a view on the stock’s direction.
China Restrictions Add Uncertainty
Not everything is clean sailing. The U.S. Department of Commerce imposed restrictions on chip equipment shipments to Hua Hong, China’s second-largest chipmaker. Lam Research was among the U.S. equipment makers affected.
The restrictions triggered a pullback in chip equipment names at the time of the news. The longer-term revenue impact on LRCX from these rules has not yet been fully quantified.
Q4 fiscal guidance came in ahead of expectations. The company is already hitting margin and revenue targets that it had originally set for calendar year 2028.
LRCX’s fiscal Q3 results beat both Stifel’s estimates and the broader Wall Street consensus, which helped drive the most recent wave of analyst upgrades.
The stock closed May 5 at or near its all-time high of $275.99.
???? Our April Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for April, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!
